Blood and fluid warming systems are widely used in clinical interventions for the prevention of non-intended hypothermia. Such systems heat fluids before and during their administration to the patient. Hypothermia can be easily prevented with blood and fluid warming systems, resulting in efficient patient management, a reduced hospital stay, and a lower risk of surgical site infections. Major complications associated with non-intended hypothermia include greater mortality rates, a long hospital stay, augmented bedding time, a higher risk of infection, and greater healthcare costs.
Blood and fluid warming systems find major usage in intensive care units, operating rooms, and emergency settings to prevent hypothermia in critical patients. Such systems comprise features such as automatic temperature flow adjustment and alarm systems. The demand for blood and fluid warming systems is supported by the growing incidence of hypothermia in clinical settings and the associated mortality.
The risk of hypothermia incidence is higher in geriatric and pediatric patients; hence, the growing birth rate and increase in life expectancy will further contribute to a greater demand for blood and fluid warming systems. Regions with cooler temperatures are the major geographic areas experiencing high demand for blood and fluid warming systems due to prevalent environmental factors. As patients under anesthesia are unable to regulate their blood temperature, the growing number of surgical procedures under anesthesia will also contribute to the growth in demand for fluid warming systems.
The global market for blood and fluid warming systems is segmented on the following bases:
By Technology
Drum/Cylinder Heating
Plate Heating
Forced Air Warming
Electric/Induction Heating
Recirculating Fluid Warming
Infrared Warming
By End-Use
emergency medical care
Hospitals
Military
Others
By Geography
North America
US
Canada
Europe
UK
Germany
Rest of Europe
AsiaPacific
Japan
China
Rest of APAC
Latin America
Brazil
Mexico
rest of Latin America
Middle East and Africa
Saudi Arabia
Rest of the Middle East and Africa
Key players identified for the blood and fluid warming systems market include, but are not limited to:
3M Company, CareFusion/Becton, Dickinson and Company Smiths Medical, The 37 Company, Biegler GmbH, Belmont Instrument Corporation, Estill Medical Technologies, Inc., Gaymar, JMW Medical Ltd., Nuova GmbH, Sarstedt AG & Co., Stihler Electronic GmbH, TSCI, and several others
This report offers the following:
An overview of the global markets for blood and fluid warming systems
Market trends assessment for the period 2013-2023, with historical information for 2013 and 2014 and projections through 2023, with respective CAGRs during 2016 and 2023
Qualitative assessment tools such as market drivers, challenges, future prospects, major commercial events, etc.
Market competition scrutiny tools such as market share analysis and an attractive investment proposition
Focus on each level of market segmentation based on product approvals, launches, and current and anticipated market dynamics.
A general overview of the industry structure
Company profiles highlight key information about the major players operating in the blood and fluid warming systems market.
Frequently Asked Questions:
The market for Blood and Fluid Warming Systems Market is expected to reach US$ XX Mn By 2023.
The Blood and Fluid Warming Systems Market is expected to see significant CAGR growth over the coming years, at XX%.
The report is forecasted from 2016-2023.
The base year of this report is 2015.
3M Company, CareFusion/Becton, Dickinson and Company Smiths Medical, The 37 Company, Biegler GmbH, Belmont Instrument Corporation, Estill Medical Technologies, Inc., Gaymar, JMW Medical Ltd., Nuova GmbH, Sarstedt AG & Co., Stihler Electronic GmbH, TSCI are some of the major players in the global market.
